| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.0008 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.002 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.003 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.004 |